Faecal lactoferrin and calprotectin in patients with Clostridium difficile infection: a case–control study
Crossref DOI link: https://doi.org/10.1007/s10096-017-3080-y
Published Online: 2017-08-12
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Barbut, F.
Gouot, C.
Lapidus, N.
Suzon, L.
Syed-Zaidi, R.
Lalande, V.
Eckert, C.
Funding for this research was provided by:
Astellas Pharma Europe (AS 25 RG 14)
License valid from 2017-08-12